Back to list

ORKIDS

University of North Carolina at Chapel Hill


Description

The main purpose of this research is to investigate whether treatment with Krill Phospholipids Concentrate (AKBM-3031) also known as Krill Oil is able to replenish the omega-3 deficiency associated with Systemic Lupus Erythematous (SLE). Omega-3 is an essential nutrient that is important in preventing and managing heart disease. In addition, this study is also being done to determine whether taking the Krill Oil has further positive effects in SLE patients with regards to slowing down the progression of and/or preventing disease flares. SLE is a disease that affects the immune system and can affect any part of the body (skin, joints, and/or organs).


Keywords:

Auto Immune Diseases


Category:

Drug or Biologic

Qualifications

 


Age
18 - 99 years


Gender
Any


Study Population

Adults diagnosed with Systemic Lupus Erythematosus (SLE), on stable dose of SLE treatment. Low seafood diet (twice per month or less).


Investigator

Saira Sheikh
Clinical Assistant Professor
Medicine-UNCP A Rheumatology

For questions, contact:

Julie Norfleet Walker
jann1@email.unc.edu
(919) 843-6619


Recruitment Period End

August 1, 2019

Location

Primary Location
Clinical & Translational Research Center
Burnett-Womack Building, 160 Dental Cir, Chapel Hill, NC 27514, USA

Study Qualifications

Gender Any

Age Range 18 - 99 years

Participant qualification(s) Adults diagnosed with Systemic Lupus Erythematosus (SLE) and on stable dose of current SLE treatment. Low seafood diet (twice per month or less).

Not eligible if: Have rapidly progressive neurologic or renal disease. Using an omega-3 prescription drug (e.g. Lovaza®, Vascepa®, etc.) or as medical food (e.g. Vascazen®, Vayarin, Onemia™ etc.) or present or recent daily use of any over the counter fish oil or krill oil or any long-chain omega-3 fatty acid dietary supplement. Require anti-coagulation medication, such as coumadin, clopidogrel, dalteparin, dypyridamole, enoxaparin, heparin or ticlopidine.

Number of Visits

    » 8 In person visit(s)

    1 screening, 7 clinic

    » 6 Remote visit(s)

    6 phone

Participation Period

48 weeks

Compensation

$50 per completed visit

By clicking I am interested, your contact information will be sent to the researcher/study coordinator for this study. The coordinator will respond by email with additional information on how to proceed.